Pharmaceutical Substance Manufacturing Grant Fund; created.

The Virginia Legislature approved file SB527 ("Pharmaceutical Substance Manufacturing Grant Fund; created."), by a recorded vote of 131 to 6. Last action: April 13, 2026.

Virginia file SB527, before the Virginia Legislature. Passed as of 2026-04-13.

Official summary

Pharmaceutical Substance Manufacturing Grant Fund. Establishes the Pharmaceutical Substance Manufacturing Grant Fund to provide grant installment awards between July 1, 2026, and July 1, 2045, in an amount not to exceed $34 million per fiscal year and in an aggregate amount not to exceed $191,255,000, to a qualified company that (i) engages in the manufacture of pharmaceutical substances, (ii) executes a memorandum of understanding with the Commonwealth, and (iii) is expected to make a capital investment of at least $4 billion and create and maintain at least 500 new full-time jobs. This bill is identical to HB 1076.

How they voted

Yes (131)

No (6)

Did not vote / other (2)

Read the official record for SB527

See everything up for a vote · This week in Virginia · See what we have filed with the clerk